
Vituro Health Successfully Completes First TULSA-PRO® Cases in the United States Following FDA 510(K) Clearance
February 4, 2020
Vituro Health is pleased to announce that it, in partnership with Choice Diagnostic Imaging, successfully completed the first three TULSA-PRO® treatments to ablate prostate tissue in patients recently diagnosed with Prostate Cancer.